Small-Molecule Drugs
Finasteride
Last reviewed: 2026-11-19
Evidence status & limitations
Specific approved products have different indications; approval is not transferable to untested combination formulations.
Regulatory status
FDA approval applies only to the named products and indications below. It does not approve every formulation or other use.
Propecia · Hair Loss
Male pattern hair loss in men only.
Authoritative label recordProscar · Benign Prostatic Hyperplasia
Symptomatic benign prostatic hyperplasia in men with an enlarged prostate.
Authoritative label record
Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.
WADA prohibited status: current list and contextKnown risks & open questions
Sexual adverse effects and pregnancy-related developmental risks are documented; it changes PSA interpretation.
Key sources
Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.
Related compounds
- Apomorphine
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Metformin
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Methylthioninium chloride
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Minoxidil
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Omeprazole
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications